Login
$NPHC
$0.00 +$0.00 (0.0%) Close

Ownership

13F as of Q2 2026 · 7.16B shares outstanding

Who owns NPHC?

By type of holder
Institutions 0.0% Insiders 0.6% Everyone else 99.4%
Concentration Top 2 holders own 0.8%
Deitsch Rik J 0.6% · Pure Raw Supplies, LLC 0.2%
Institutional ownership
0.0%
0.0 pts vs last qtr
Institutional holders
0
0 vs last qtr
Net shares bought
0
by institutions in Q2 2026
New / sold out
0 / 0
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Nutra Pharma Corp in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2023–FY2025
+2.3%
+1.12% a year
Each share's claim on the business
−2.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $26.7K
over 3 fiscal years
Diluted shares, split-adjusted
7.38B7.62B7.86B2023: 7.61B shares'232024: 7.67B shares'242025: 7.78B shares'25
Buybacks Stock-based comp
$0$13.3K$26.7K2023 buybacks: $02023 stock comp: $0'232024 buybacks: $02024 stock comp: $0'242025 buybacks: $02025 stock comp: $26.7K'25

How patient are the owners?

No 13F manager reports holding NPHC.

Super Investors

Investment managers reporting NPHC on Form 13F
No 13F manager reports holding NPHC yet.

Institutional Funds

Mutual funds and ETFs reporting NPHC on Form N-PORT; together they hold 0.0% of the company
No fund reports holding NPHC yet.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
DR
Deitsch Rik J
Insider
Shares
43.3M
% of company
0.60%
Change vs last qtr
—
Held since
—
PR
Pure Raw Supplies, LLC
5%+ holder13D · 100.0%
Shares
12.0M
% of company
0.17%
Change vs last qtr
—
Held since
—

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support